org placeholder image

Edward Povilaitis

Senior Scientist, Formulations at Karyopharm Therapeutics

  • LinkedIn
map
KARYOPHARM THERAPEUTICS

KARYOPHARM THERAPEUTICS

  • description Description
    Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directe...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Karyopharm Therapeutics Org Chart and Mapping

Employees

Jessica Cardenas

Sr. Director, Global Publications Lead

Shane Miller

Clinical Project Manager

Zachary Henney

Principal Medical Science Liaison, Central Region

Juan Jc

Hematology Oncology Specialist Rare Disease

Travis Cooper

Senior Medical Science Liaison

Frequently Asked Questions Regarding Edward Povilaitis

Answer: Edward Povilaitis works for Karyopharm Therapeutics as Senior Scientist, Formulations

Answer: Edward Povilaitis’s role in Karyopharm Therapeutics is Senior Scientist, Formulations

Answer: Edward Povilaitis's email address is e***@gmail.com

Answer: Edward Povilaitis's business email address is e****@boehringer-ingelheim.com

Answer: Edward Povilaitis’s direct phone number is (***)-***-****

Answer: Edward Povilaitis works in the industry of: Pharmaceuticals

Answer: Edward Povilaitis works Karyopharm Therapeutics located at 85 Wells Ave Fl 2, Newton, Massachusetts, 02459, United States

Answer: Karyopharm Therapeutics's Senior Scientist, Formulations is Edward Povilaitis

Answer: Edward Povilaitis contact details:

  • Phone number  :  (***)-***-****
  • Email  :  e****@boehringer-ingelheim.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access